Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06989619 · ClinicalTrials.gov registry record · NA

Leveraging Social Networks to Improve Sleep and Mindfulness Among Older Adults in Residential Housing Facilities

A NA study of Aging and Sleep, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06989619: Recruiting NA study of Aging and Sleep, sponsored by Brigham and Women's Hospital.

NCT06989619 is a NA study of Aging and Sleep that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 45 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06989619, a NA study of Aging and Sleep, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to design a sleep and mindfulness intervention to improve sleep, quality of life, and cognitive function among older adults.

Primary Outcome

Time it takes to recruit participants into the study

Interventions

  • BEHAVIORAL Sleep health and mindfulness intervention

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2025-01-01
Est. Completion 2026-09-15
Phase NA
Brigham and Women's Hospital

937 total trials

What NCT06989619 shows while recruiting

NCT06989619 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Sleep health and mindfulness intervention is the first listed.

NCT06989619 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06989619 about?

NCT06989619 is a clinical study titled "Leveraging Social Networks to Improve Sleep and Mindfulness Among Older Adults in Residential Housing Facilities". The aim of this study is to design a sleep and mindfulness intervention to improve sleep, quality of life, and cognitive function among older adults.

What is the current status of trial NCT06989619?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-01-01. Estimated completion is 2026-09-15.

What conditions does trial NCT06989619 study?

This clinical trial studies the following conditions: Aging, Sleep, Cognitive Impairment.

What interventions are being tested in trial NCT06989619?

The interventions under investigation include: Sleep health and mindfulness intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06989619?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06989619 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06989619's enrollment target sits among peer trials

45 166th of 262 higher than 96 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06989619, the US trial registry maintained by the National Library of Medicine. NCT06989619 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.